Gene · 1859
Papers3,825
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 3,825
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetic architecture and molecular pathogenesis of Parkinson's disease: emerging mechanisms and therapeutic targets. | Metab Brain Dis | 2026 | 42803978 | PubTator, text mining | PubMed |
| Targeting DYRK1A with rationally designed pyrazine-guanidine hybrids for Alzheimer's disease: design, synthesis, and biological evaluation. | RSC Adv | 2026 | 42780659 | PubTator, text mining | PubMed |
| Harmine selectively enhances human beta cell identity markers and function via protein kinase A pathways. | Diabetologia | 2026 | 42766004 | PubTator, text mining | PubMed |
| Network modeling predicts how DYRK1A inhibition promotes cardiomyocyte cycling after ischemia/reperfusion injury. | JCI Insight | 2026 | 42752366 | PubTator, text mining | PubMed |
| DYRK kinases phosphorylate IL-17RA at S801. | Serican J Med | 2026 | 42746556 | PubTator, text mining | PubMed |
| Baseline cellular state shapes the molecular impact of mutant Kirsten rat sarcoma viral oncogene homologue (KRAS) alleles in reconstituted pancreatic cancer cells. | Mol Omics | 2026 | 42720273 | PubTator, text mining | PubMed |
| Amyloid precursor protein dosage normalization rescues neurogenesis and Alzheimer's Disease phenotypes associated with Down Syndrome. | Med Res Arch | 2026 | 42677302 | PubTator, text mining | PubMed |
| In silico structure-based design of superior DYRK1A enzyme inhibitors. | Comput Biol Chem | 2026 | 42673670 | PubTator, text mining | PubMed |
| Small-molecule DYRK1A Inhibitors for β-Cell Regeneration in Diabetes: Structural Insights and Medicinal Chemistry Advances. | Mini Rev Med Chem | 2026 | 42634309 | PubTator, text mining | PubMed |
| Design, synthesis and biological evaluation of quinazoline-carbazole derivatives as dual TXNIP/DYRK1A inhibitors for the treatment of type 2 diabetes mellitus. | Mol Divers | 2026 | 42631845 | PubTator, text mining | PubMed |
| Quantitation of Cirtuvivint (SM08502) in Human Plasma by LC-MS/MS. | Biomed Chromatogr | 2026 | 42610493 | PubTator, text mining | PubMed |
| Transcranial direct current stimulation enhances cognitive performance and modulates QEEG beta- and theta-band power in patients undergoing whole-brain radiotherapy. | IBRO Neurosci Rep | 2026 | 42598132 | PubTator, text mining | PubMed |
| Small-molecule cocktail 2SM promotes heart regeneration via inducing embryonic-like cardiomyocyte state. | Cell Regen | 2026 | 42579202 | PubTator, text mining | PubMed |
| Overexpression of DYRK1A in down syndrome: Analysis of kinase activity. | Biochem Biophys Rep | 2026 | 42569056 | PubTator, text mining | PubMed |
| First- and Second-Trimester Cardiovascular Anomalies in Trisomy 21 Fetuses: Anatomy, Embryology, Genetics and Imaging. | J Pers Med | 2026 | 42506084 | PubTator, text mining | PubMed |
| Integrative Insights Into DYRK1A From Molecular Function to Therapeutic Advancement. | Chem Biol Drug Des | 2026 | 42494118 | PubTator, text mining | PubMed |
| Global Phosphoproteome Analysis Identifies CLK4 Co-Regulatory Pathways Driving Tumor-Specific Dysregulation. | OMICS | 2026 | 42484065 | PubTator, text mining | PubMed |
| From Structure to Selectivity: Integrating CADD and AIDD in Rational Medicinal Chemistry Strategies for DYRK1A Inhibitor Discovery. | J Med Chem | 2026 | 42476932 | PubTator, text mining | PubMed |
| Kinome-wide CRISPR/Cas9-knockout screening reveals critical protein kinases in vasopressin V2-receptor signaling. | bioRxiv | 2026 | 42465376 | PubTator, text mining | PubMed |
| The Role of Genetic Alterations in the Emergence of Alzheimer's Disease in Down Syndrome: A Review. | Eur J Neurosci | 2026 | 42442802 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1859/papers